{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:49:08Z","timestamp":1761824948507,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2019QH1039"],"award-info":[{"award-number":["2019QH1039"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.advms.2022.12.001","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:31:48Z","timestamp":1672925508000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-4430","authenticated-orcid":false,"given":"Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-ye","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-gui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-zhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2022.12.001_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.advms.2022.12.001_bib2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.advms.2022.12.001_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.advms.2022.12.001_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/cncr.10407","article-title":"A\u00a0prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.advms.2022.12.001_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00795-006-0311-1","article-title":"Angiogenic cell therapy for hepatic fibrosis","volume":"39","author":"Ueno","year":"2006","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.advms.2022.12.001_bib6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.advms.2022.12.001_bib7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A\u00a0meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.advms.2022.12.001_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7314\/APJCP.2013.14.1.217","article-title":"Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients","volume":"14","author":"Li","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.advms.2022.12.001_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.advms.2022.12.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.advms.2022.12.001_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphys.2016.00047","article-title":"Promising therapy candidates for liver fibrosis","volume":"7","author":"Wang","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.advms.2022.12.001_bib12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1183\/09031936.00198013","article-title":"Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis","volume":"45","author":"Ogura","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.advms.2022.12.001_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.42.5.715","article-title":"Evidence for altered hepatic matrix degradation in genetic haemochromatosis","volume":"42","author":"George","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.advms.2022.12.001_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(02)00245-3","article-title":"Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production","volume":"37","author":"Di Sario","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.advms.2022.12.001_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0168-8278(02)00272-6","article-title":"Pirfenidone effectively reverses experimental liver fibrosis","volume":"37","author":"Garcia","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.advms.2022.12.001_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/TP.0b013e3181ae3392","article-title":"Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses","volume":"88","author":"Visner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.advms.2022.12.001_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.advms.2022.12.001_bib18","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1158\/1078-0432.CCR-04-1393","article-title":"2-Methoxyestradiol inhibits hypoxia-inducible factor 1\u03b1, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma","volume":"10","author":"Ricker","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2022.12.001_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1478-3231.2004.0961.x","article-title":"Hypoxia potentiates transforming growth factor-\u03b2 expression of hepatocyte during the cirrhotic condition in rat liver","volume":"24","author":"Won-II","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.advms.2022.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5720413","article-title":"Comparison of the treatment efficiency of bone marrow-derived mesenchymal stem cell transplantation via tail and portal veins in CCl4-induced mouse liver fibrosis","author":"Truong","year":"2016","journal-title":"Stem Cells Int. 2016"},{"key":"10.1016\/j.advms.2022.12.001_bib21","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1586\/14737140.8.10.1623","article-title":"TACE versus TAE as therapy for hepatocellular carcinoma","volume":"8","author":"Maria","year":"2008","journal-title":"Expert Rev Anticanc"},{"key":"10.1016\/j.advms.2022.12.001_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/hh1301.092678","article-title":"Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase","volume":"89","author":"Gorlach","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.advms.2022.12.001_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jvir.2007.02.031","article-title":"Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1\u03b1 in rabbit VX2 liver tumors","volume":"18","author":"Rhee","year":"2007","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.advms.2022.12.001_bib24","article-title":"Regulation of TGF-\u03b2 family signaling by inhibitory smads","volume":"9","author":"Miyazawa","year":"2016","journal-title":"CSH Perspect Biol"},{"key":"10.1016\/j.advms.2022.12.001_bib25","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajpath.2014.01.020","article-title":"Mechanisms of action of acetaldehyde in the up-regulation of the human \u03b12(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7","volume":"184","author":"Karina","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.advms.2022.12.001_bib26","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"AM J Physiol - Gastr L."},{"key":"10.1016\/j.advms.2022.12.001_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s10620-005-2669-7","article-title":"Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression","volume":"50","author":"Kanno","year":"2005","journal-title":"Dig Dis"},{"key":"10.1016\/j.advms.2022.12.001_bib28","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1038\/emm.2014.49","article-title":"Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis","volume":"46","author":"Kim","year":"2014","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.advms.2022.12.001_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibro contractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J\u00a0Pathol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262200044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262200044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:43:09Z","timestamp":1761824589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611262200044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S189611262200044X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2022.12.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}